Immune Response on Optimal Timing and Fractionation Dose for Hypofractionated Radiotherapy in Non–Small-Cell Lung Cancer

Background: The intervention timing of immune checkpoint inhibitors (ICIs) and radiotherapy fractionations are critical factors in clinical efficacy. This study aims to explore dynamic changes of the tumor immune microenvironment (TIME) after hypofractionated radiotherapy (HFRT) at different timepoi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Xianlan, Li, Jixi, Zheng, Linpeng, Yang, Qiao, Chen, Xu, Chen, Xiewan, Yu, Yongxin, Li, Feng, Cui, Jianxiong, Sun, Jianguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819084/
https://www.ncbi.nlm.nih.gov/pubmed/35141280
http://dx.doi.org/10.3389/fmolb.2022.786864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819084/
https://www.ncbi.nlm.nih.gov/pubmed/35141280
http://dx.doi.org/10.3389/fmolb.2022.786864

Ejemplares similares